Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/55CE4CE6.svg?ark=w1%2F20260526%2F55CE4CE6)](https://nobleid.org/work/w1/20260526/55CE4CE6)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors